⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Pharmacosmos Therapeutics Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Pharmacosmos Therapeutics Inc.
↗Holbæk, Denmark
Pharmacosmos is a global, family-owned pharmaceutical company founded in 1965, specializing in carbohydrate chemistry and the development of innovative treatments for iron deficiency and iron deficiency anemia. The company has expanded its focus to include oncology following the 2024 acquisition of G1 Therapeutics, Inc.
Headquartered in Holbæk, Denmark, with a significant US presence in Morristown, NJ, the company operates in over 80 countries. It is known for its expertise in iron metabolism and blood-related disorders, maintaining a vertically integrated model that includes research, development, and manufacturing of clinical-grade dextran and iron complexes.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Specialty Pharmaceuticals
SIZE & FINANCIALS
Employees:501-1000
Revenue:$500M-$1B
Founded:1965
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Iron complexes
Trial Phases:-
FDA Approvals:2
EMA Approvals:2
CORPORATE STRUCTURE
Subsidiaries:Pharmacosmos Therapeutics Inc. (US), Pharmacosmos UK/IE, Pharmacosmos Germany, Pharmacosmos Nordic, Pharmacosmos Canada
Key Partnerships:G1 Therapeutics (Acquired)
COMPETITION
Position:Leader
Competitors:Vifor Pharma, Sanofi, Johnson & Johnson
LEADERSHIP
Key Executives:
Tobias S. Christensen - CEO
Josh Franklin - President, Pharmacosmos Therapeutics Inc. (US)
Claes C. Strøm - Chief Commercial Officer
Scientific Founders:Henry M. Christensen
Board Members:Jacob Tolstrup (Chairman), Lars Christensen (Deputy Chairman)
LINKS
Website:pharmacosmos.us
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Pharmacosmos Therapeutics Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.